Impact of a Booster Course of Antenatal Steroids on Neonatal Outcome in Patients With Premature Rupture of the Membranes

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

194

Participants

Timeline

Start Date

March 3, 2016

Primary Completion Date

August 15, 2022

Study Completion Date

October 31, 2022

Conditions
Premature Birth
Interventions
DRUG

Betamethasone - ACTIVE

antenatal corticosteroid (ACS) is to be given by injection 24 hours apart for two doses.

OTHER

Normal Saline - PLACEBO

normal saline of the same quantity as with the experimental drug is to be given by injection 24 hours apart for two doses

Trial Locations (9)

36617

University of South Alabama Medical Center, Mobile

37920

University of Tennessee Medical Center, Knoxville

60612

Lousiana State University Health Science, Shreveport

70121

Ochsner Clinic Foundation, New Orleans

80218

Presbyterian/St Luke's Hospital, Denver

85014

Phoenix Perinatal Associates, Phoenix

95008

Good Samaritan Hospital, San Jose

90801-1428

Long Beach Memorial Medical Center, Long Beach

98122-4307

Swedish Medical Center, Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pediatrix

OTHER